Terry Bowlin
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$5.6MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $5.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 1, 2021 | NIH | SBIR Phase II Development of Filociclovir for the Treatment of Ocular Adenoviral Infections and Keratoconjunctivitis | $1.5M | MICROBIOTIX, INC. |
| Feb 3, 2021 | NIH | SBIR Phase II Screening for rAAV transduction enhancers | $3.0M | MICROBIOTIX, INC. |
| Aug 13, 2018 | NIH | STTR Phase I Discovery of Zika virus therapeutics using a replicon assay | $585K | MICROBIOTIX, INC. with UNIVERSITY OF TEXAS MED BR GALVESTON |
| Jan 27, 2017 | NIH | SBIR Phase I Screening for rAAV transduction enhancers | $591K | MICROBIOTIX, INC. |
Peer ranks
Federal funding#219
Awards as PI#566
Patents#273
Companies
- MICROBIOTIX, INC.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.